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Oxygen-derived free radicals are normally generated in many pathways. These radicals can interact with various cellular
componentsandinducecellinjury.Whenfreeradicalsexceedtheantioxidantcapacity,cellinjurycausesdiversepathologicchanges
in the organs. The imbalance between the generation of free radicals and antioxidant defence is known as oxidative stress. The eye
can suﬀer the eﬀect of oxidative damage due to the etiopathogenesis of some pathological changes related to oxidative stress. This
paper reviews the role of oxidative stress in the onset and progression of damage in diﬀerent eye structures, the involvement of
the antioxidant network in protecting and maintaining the homeostasis of this organ, and the potential assessment methodologies
used in research and in some cases in clinical practice.
1.Introduction
The eye is an organ that captures light stimuli of the
environment and transforms these light signals into nerve
impulses that travel through the optic nerve to be processed
in images by the brain. Today, there has been an increase
in visits for eye diseases in both human medicine and
veterinary medicine. The main causes of this increase can be
attributed to xenobiotics derived of environmental pollution
[1], increasing of the ultraviolet radiation intensity [2], and
feeding based on fats and carbohydrates associated with
physical inactivity and increasing of degenerative diseases
such as diabetes and cardiovascular problems [3, 4].
All the above factors can generate harmful chemicals
to ocular tissues and are called oxidants agents or free
radicals (FRs). To protect against external agents, the eye has
several nonspeciﬁc defence mechanisms, such as eyelids, tear
ﬁlm, cornea, and lens. When harmful agents have overcome
these barriers, other speciﬁc mechanisms operate based on
molecules called antioxidants [5].
This paper reviews the role of oxidative stress in the
onset and progression of damage in diﬀerent eye structures,
the involvement of the antioxidant network in protecting
and maintaining the homeostasis of this organ, and the
assessmentmethodologiesusedinresearchandinsomecases
in clinical practice.
1.1. Free Radicals. An FRs represents any chemical species
that has one or more unpaired electrons rotating in its
external atomic orbits [6]. SeveralauthorshaveclassiﬁedFRs
according to the functional group in their molecule. The
most frequent one is an oxygen FRs, in which oxygen is
the functional centre. This species is called reactive oxygen
species (ROS) and is the most relevant in eye damage. ROS is
a generic name that includes FRs and those chemical species
that act like oxidants but that are not FRs. The ﬁrst group
includes superoxide anion (O2
￿−), hydroxyl radical (OH￿−),
peroxyl radical (LOO￿), and alkoxyl (LO￿)[ 3, 7].
Nonradical species behave as oxidants or are easily
converted into FRs. Within this group are hydrogen peroxide
(H2O2), hypochlorous acid (HClO), singlet oxygen (1O2),
and ozone (O3)[ 8].
ROS are generally formed from normal metabolic reac-
tions and exogenous factors can increase them [3, 9].
The ﬁrst ones are mainly those formed in the mitochon-
dria during ATP synthesis, in the peroxisomes during β-
oxidation of fatty acids and D-amino acids, as consequence
of activation of P-450 enzyme system or by macrophages2 Veterinary Medicine International
and neutrophils as part of the immune response [10–12].
The exogenous factors can include an excessive intake of
some transition metals such as iron (Fe) and copper (Cu),
ultraviolet radiation, drugs, and pollution [12, 13].
1.2. Oxidative Stress. This alteration is produced when there
is an imbalance in FRs generation and the antioxidant
defence mechanism. Normal metabolic processes generate
large amounts of ROS. However, when FRs generation
exceeds the capacity of adaptation and cellular defence, a
condition known as oxidative stress is produced. This does
not deﬁne if the alteration is due to an increase in FRs or to
a decrease in a homeostatic response in tissues. Given that
oxidative injury can be related to a deﬁciency of protective
substances and several protective substances are nutrients,
a close relationship between oxidative stress and nutritional
state can be established. Oxidative stress aﬀects the cell
integrity, because biomolecules such as DNA, proteins, and
lipidsaredamagedconsequenceofthisprocess.Almostevery
biologicalmacromoleculescanbeoxidized byROS;however,
lipids and proteins are the most labile biomolecules presents
in the eyeball [3, 9].
1.2.1. Lipid Peroxidation. The action of ROS on lipids is
known as lipoperoxidation or lipid peroxidation (LPO), and
the mechanism, measurement, and interpretation have been
widely reviewed. The LPO is particularly destructive, for it
develops as a self-perpetrating chain reaction. This process
is initiated when ROS removes a hydrogen atom from the
methylene group of a polyunsaturated fatty acid (PUFA)
and form a lipid FRs. Quickly, it adds oxygen molecule
and becomes a fatty acid peroxyl FRs and oxidized to other
PUFA initiating new reactions. This mechanism is facilitated
by the presence of transition metal ions (Cu and Fe) and
the double bonds contained in the chain of PUFA [7, 8].
The end products of LPO are degraded and originate new
cytotoxic compounds such as 4-hydroxynonenal (4-HNE)
andmalondialdehyde(MDA).Theconsequencesofoxidative
damage to PUFA are more evident when they are part
of cellular or subcellular membranes, because it alters its
cohesion, ﬂuidity, permeability, and metabolic function [6,
9, 14].
1.2.2. Protein Oxidation. While proteins, peptides, and
amino acids are also targets for ROS, its modiﬁcation is
less harmful than lipids, because the progress of reaction
is slow. However, the ocular tissue has a high percentage
of proteins, and then, any alteration on the proteins is
very important [15, 16]. It has been observed that the
presence of signiﬁcant amounts of aromatic and sulfur
amino acids in a protein structure makes it more vulnerable
to the FRs [6]. This condition is observed in the lens,
whose protein composition contains high proportions of
tryptophan, tyrosine, phenylalanine, histidine, methionine,
and cysteine amino acids that can be modiﬁed by ROS,
producing adducts and aggregation and altered enzyme
function. Peptide bonds are also susceptible to be attacked
by FRs. These bonds can be modiﬁed after the oxidation of
proline residues. In addition, end products could amplify the
initial damage [13].
2.AntioxidantProtectionMechanisms
AssociatedtotheEye
The ocular tissue has a protection system against oxidative
damage that can be classiﬁed into enzymatic and nonenzy-
matic antioxidants [17].
2.1. Enzymatic Antioxidants. Enzymatic antioxidants cat-
alyze electron transference from a substrate toward ROS.
Later, the substrates or reducing agents used in these
reactions are regenerated to be used again, and they achieve
this by using the NADPH produced in diﬀerent metabolic
pathways [6]. The main antioxidant enzymes protecting the
eye against ROS are superoxide dismutase (SOD), catalase
(CAT), and glutathione peroxidase (GPx). Each of these
enzymes catalyzes the reduction of a particular type of ROS
[18].
2.1.1. Superoxide Dismutase (EC 1.15.1.1, SOD). Superoxide
dismutase catalyzes the dismutation of O2
￿− into H2O2 and
O2. This enzyme is a metalloprotein and has three isoforms,
which have diﬀerent cellular locations and employ diﬀerent
cofactors. The isoforms Cu-SOD and Zn-SOD are located
in the cytosol and extracellular ﬂuid, whereas the isoform
Mn-SOD is located in the mitochondrial matrix [9, 19].
All isoforms have been identiﬁed in the cornea (epithelium
andendothelium)[18,20–22],lensepithelium[23],aqueous
humor [24],iris,ciliarybody[25],andretina(innersegment
layer of photoreceptor cells and pigment epithelium) [26,
27].
2.1.2. Glutathione Peroxidase (EC 1.11.1.9, GPx). This selen-
oprotein can reduce H2O2 and organic hydroperoxides into
water and alcohol, respectively, using reduced glutathione
(GSH) as electron donor. Four GPx isoforms have been
described, and they are all found in diﬀerent locations:
cellular GPx, extracellular or plasmatic GPx, phospholipid
hydroperoxide GPx, and gastrointestinal GPx. All GPx are
an important defence against ROS-mediated damage to lipid
membranes and other molecules susceptible to oxidation
[6]. GPx has been detected in cornea (epithelium and
endothelium)[18,28],lensepithelium,aqueoushumor[24],
ciliary body, choroid, and retina (inner segment layer of
photoreceptors and retinal pigment epithelium) [21, 27, 29].
2.1.3. Catalase (EC 1.11.1.6, CAT). This hemoprotein con-
tains four heme groups. The enzyme is present in per-
oxisomes mitochondria and cytoplasm and catalyzes the
conversion of H2O2 into H2Oa n dO 2. This function is
shared with GPx, but CAT has higher aﬃnity when H2O2 is
f o u n di nh i g hc o n c e n t r a t i o n s[ 14]. CAT has been detected
in the cornea (epithelium and endothelium) [18, 28], lens
epithelium, aqueous humor [24], ciliary body, iris [25], and
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2.2. Nonenzymatic Antioxidants. These antioxidants consti-
tute a heterogeneous group, and they act by donating an
electron to an FRs in order to stabilize it and create chemical
species that are less noxious to cell integrity [6]. The main
nonenzymatic antioxidants present in the globe are ascorbic
acid, vitamin E, vitamin A, and GSH [5].
2.2.1. Ascorbic Acid. It is an antioxidant that is soluble at
physiological pH in most tissues as ascorbate anion. Its
antioxidant role is to reduce O2
￿−,O H ￿− and lipid hydroper-
oxide into more stable forms [14]. Another function of
ascorbate is related with the recycling of α-tocopheryl radical
to α-tocopherol. However, this process transforms ascorbate
anion into dehydroascorbate anion radical, which can be
reducedbydehydroascorbatereductaseandGSHreturningit
to native state. Also, ascorbate can act as a pro-oxidant in the
presence of excessive concentrations of ions Fe+3 and Cu+2
[6, 7, 14]. Ascorbate was detected in cornea [31], aqueous
humor [32, 33], lens [34], vitreous humor [35], and retina
[29].
2.2.2. Vitamin E. The term vitamin E is a generic name for
a family of eight compounds, four tocopherols, and four
tocotrienols, of which the α-tocopherol is the most active
antioxidant and the primary defence liposoluble antioxidant
in membranes. The α-tocopherol converts O2
￿−,O H ￿− and
LOO￿ into less reactive molecules. The phenolic hydroxyl
on the chroman ring is responsible for the antioxidant
function [9]. In parallel, α-tocopherol can stop the chain
reaction of ROS during the attack on cell membranes
[36]. To stabilize ROS, the α-tocopherol is converted into
the α-tocopheryl radical, whose shape is stable and does
not react with biomolecules. α-tocopheryl radical can be
regenerated to its original through reactions mediated by
vitamin C, GSH, and lipoic acid [6]. The antioxidant ability
of α-tocopherol depends on the concentrations of those
compounds, which keep α-tocopherol in its reduced state
in instances of oxidative stress [36]. It is possible that an
overproduction of ROS can cause a signiﬁcant drop of active
vitamin E tissue concentration. The α-tocopherol has been
detected in lens [37], aqueous humor, and retina [29].
2.2.3. Vitamin A. This generic term includes those com-
poundsfromanimalsthatshowvitaminAbiologicalactivity.
The major precursor of vitamin A is β-carotene, which is the
most eﬃcient neutralizer of 1O2. The antioxidant properties
of vitamin A derive from its chemical structure, which
consists of long chains of conjugated double bonds, this
allows to convert O2
￿− yL O O ￿ into less reactive substances
[14]. Carotenoids are eﬀective antioxidants but diﬀer in their
concentrations in ocular tissues. Other carotenoids, with
the exception of lutein/zeaxanthin, are found only in trace
quantities in the ocular tissues except in the ciliary body,
where aqueous humor is produced. In contrast, lutein and
z e a x a n t h i na r ef o u n di nh i g hc o n c e n t r a t i o n si ns o m eo c u l a r
tissues, such as the macula, retina, and lens [37, 38].
2.2.4. Glutathione (GSH). Its reduced form corresponds
to a tripeptide (gamma glutamyl-cysteinyl-glycine) with a
sulfhydryl group (-SH) in the active site. GSH transfers
electrons to oxidized specie such as hydroxyl radicals and
carbonyls, becoming in turn an oxidized product (GSSG)
[9, 14]. During this reaction, GSH donates a pair of H so
that two GSH molecules are oxidized to produce GSSG. Also,
GSH acts as cosubstrate of GPx in the removal of H2O2
and organic peroxides, and it can reduce tocopheryl FRs and
dehydroascorbate returning them to original form [6, 36].
GSH is important for the maintenance of lenticular
proteins in a reduced state [30]. This has been found in
lens [39, 40], cornea, and retina [41], being next to ascorbic
acid one of the main mechanism of defence against photo-
oxidation [15].
3. OxidativeStress andGlobe
The eye is aﬀected by oxidative stress due to its physical and
metabolic characteristics. The eye is a metabolically active
organ, consuming large amount of ATP. In addition, the
transparency of the cornea, aqueous humor, lens, vitreous
and retina allows a constant photochemical ROS generation
[17, 32]. All ocular tissues and ﬂuids are susceptible to
damage by oxidative stress; however, those described below
aﬀect severely the function of the eye due to the physical
changes they undergo [18].
3.1. Cornea. The main ROS generation occurs in the cornea
duetohighexposuretoultravioletradiation[18].Thecornea
is the main barrier which stops ultraviolet radiation (UVA-
UVB). It absorbs 92% of UV-B and 60% of UV-A, and the
highest degree of absorption occurs in the surface layers [42,
43].
UV radiation produces changes in the cornea, such as
blocking epithelial cells proliferation and reduced epithelial
thickness [44], decrease in corneal antioxidant such CAT,
GPx, and SOD [18], decreased Na+/K+ ATPase in the corneal
epithelium and endothelium, causing signiﬁcant increase in
corneal hydration and changes in the transparency of the
cornea and release of proinﬂammatory cytokines [2, 20, 45,
46]. UV radiation also causes alteration of the physiological
properties of glycosaminoglycans in the stroma, becoming
more susceptible to degradation by tissue enzymes from
stimulated phagocytic cells [18, 47].
It has been determined that the primary antioxidant
defence is ascorbic acid (highly concentrated in the corneal
centre, right in the pupil area) and SOD activity. CAT and
GPx enzymes have a secondary role [33]. However, when an
episode of oxidative stress is triggered, the enzymatic activity
b e g i n st or e d u c e ,ﬁ r s tC A Ta c t i v i t y ,t h e nG P xa c t i v i t y ,a n d
ﬁnally SOD activity begin to reduce, thereby increasing the
amount of H2O2 further damaging the cornea [18, 20].
3.2. Aqueous Humor. ROS generation in the aqueous humor
is due primarily to UV radiation [18] and inﬂammatory
processes that occur in adjacent structures [48]. Aqueous
humor contains ascorbic acid, proteins, and some amino
acids (tyrosine, phenylalanine, cysteine, and tryptophan),
involved in UV-B absorption by allowing only a small
fraction of these radiation reach the posterior segment of
globe [18]. The UV radiation absorption in the aqueous4 Veterinary Medicine International
humor causes an increase in H2O2 concentration, which,
in turn, decreases the metabolism of GSH. It has been
determined that ascorbic acid plays a fundamental role as
UV ﬁlters in mammals, having a greater concentration in
the aqueous humor from diurnal animals than nocturnal
animals [17]. Also, ascorbic acid concentration in aqueous
humor is higher than blood plasma [32, 48, 49].
Another source of formation of large amounts of ROS
was observed after surgery, paracentesis, or uveitis due
to an increase in the amount of proteins and cells in
aqueous humor [32, 48]. There is evidence that after
lenticular surgery, the total antioxidant capacity of aqueous
humor decreased up to 40%, mainly due to the decreased
concentration of ascorbic acid [32, 48]. This fact was also
observed in human patients with idiopathic acute anterior
uveitis [50].
The increase in the H2O2 concentration in the aqueous
humor may cause damage to corneal endothelium, lens, and
ciliary body, especially trabecular network. In vitro studies
have shown that a decrease in the facility of aqueous humor
outﬂow occurs when an increased of H2O2 concentration
is present, and this may be grounds for diseases such as
glaucoma [51].
3.3. Lens. T h el e n si sm o s ta ﬀected by oxidative damage,
because it is an avascular structure and has a constant
and spare production of lenticular proteins. It is highly
exposed to UV radiation and shows a marked reduction
of antioxidants levels in the lenticular nucleus. In addition,
changes on the aqueous humor composition can aﬀect
the (inﬂammation of adjacent structures and metabolic
disorders such as diabetes) [5, 51].
Lenticularmetabolismisrelatedtoenergyproductionfor
protein synthesis and maintenance of osmotic balance. The
pentose phosphate pathway, via glucose-6-phosphate dehy-
drogenase (G-6-PD) activity, provides reducing equivalents
(NADPH) for keeping the lens in a reduced state [40].
The mechanism proposed to explain the lenticular
opacity is the oxidation of the crystalline (α, β,a n dγ-
crystalline), mainly lens proteins [51, 52]. The photo-
oxidationofthiolgroupsonlenscrystallinsproducedisulﬁde
adducts and molecules that lead to protein aggregation
and hence the cataract development [5]. Besides protein
aggregation, there are also alterations in the Na+/K+ ATPase
[51]. It has been determined that damage at the protein level
byoxidativeprocessesisincreaseswithageinhumanlensand
is signiﬁcantly greater in those with cataracts than normally
transparent crystalline [16]. An increase of cystine levels
(disulﬁde groups) and a decrease in cysteine concentration
(sulfhydryl groups) during the cataract genesis have been
demonstrated. Also an increase in disulﬁde-sulfhydryl ratio
from soluble and insoluble proteins of human cataractous
lenses is higher when the lenticular opaciﬁcation increases
[53].
Ascorbic acid and GSH are major defence mechanisms
againstphoto-oxidationinthelensandaqueoushumor[15].
The concentration of GSH in the lenticular epithelium is
as high as that in the liver and its concentration decreases
by exposure to UV radiation [54] and cataracts cases [40].
No diﬀerences were found between erythrocyte antioxi-
dant enzymes from animals with and without cataracts,
but MDA plasma levels are increased and ascorbic acid
concentrations decreased from animals with cataracts [49].
Others antioxidants present in lens, like lutein-zeaxanthin,
retinoid, and tocopherol contents, do not show diﬀerences in
concentration between normal and cataractous lenses [37],
also,onestudyshowsthatconcentrationofα-tocopherolwas
signiﬁcantly higher in cataract lenses than clear lenses [55].
3.4. Retina. The retina is the neurosensorial tissue of the
eye, and it is extremely rich in polyunsaturated lipids. This
characteristicmakesitparticularlysensitivetoROS[56].The
main generation of ROS in the retina is due to the presence
of cells with high oxygen consumption rate [57], exposure to
UV radiation, and the presence of diseases that directly aﬀect
the vascular irrigation such as glaucoma [27].
In the retina, the light is focused directly on cells group
locatedinarichlyoxygenatedplace.Thepresenceofavariety
of pigments (melanin, lipofuscin, and lutein) provides an
optimum condition for photosensitizing reactions, generat-
ingROS.Theoutersegmentphotoreceptormembraneisrich
in polyunsaturated lipids and is where most damage occurs
[51].
The ﬁnal common pathway of a group of diseases associ-
ated to decreased sensitivity and function of retinal ganglion
cells, cells death, enlargement of the optic nerve head, visual
ﬁeld reduction, and blindness is glaucoma. Oxidative stress
may contribute to the etiology and progression of glaucoma
[58], the ischemia, and reperfusion process aﬀects the retina
increasing the nitric oxide production and other FRs in
vitreous and aqueous humor [59]. The LPO is triggered,
and it is considered the cause of injury and death of retinal
ganglion cells and subsequent optic nerve damage [60].
Antioxidant protection exists in the retina, and this is mainly
due to C and E vitamin, carotenoids, GPx, SOD and CAT
enzymes, and GSH compound [29, 51, 61].
4. Evaluation of Oxidative Stress
The measurement of biomarkers of oxidative stress varies
depending on the structure to be evaluated in the globe.
Oxidant and antioxidant agents vary in the diﬀerent ocular
tissuesandﬂuids.Itispossibleevaluatetheprotectionand/or
existing damage [32].
4.1. Protection Assessment. The antioxidant protection can
be estimated by measurements of antioxidant compound
concentrations (proteins, peptides, or vitamins), antioxidant
enzyme activities, or the antioxidant capacity as a whole in
each tissue or ﬂuid of globe [32, 68].
The presence of SOD, GPx, and CAT in the globe can be
evaluatedinvitrousingbiochemicalandimmunohistochem-
ical methods [18, 29, 30]. Also, it is possible to determine
the SOD activity in situ [18]. Ascorbic acid, carotenoids,
and tocopherols can be determined by high-pressure liquid
chromatography (HPLC) [29, 32, 37, 48]. The activity of
fat-soluble antioxidants can be estimated by quantifying the
resistance to oxidation of low density lipoprotein [6].Veterinary Medicine International 5
Table 1: Incidence of eye disease compared with antioxidant intake and/or plasma levels of antioxidants molecules in humans.
Authors Objective Antioxidants Conclusion
Berendschot et al.
(2002) [62]
376 subjects of 18 to 75 years. To investi-
gate whether serum levels of antioxidants
inﬂuence the lens optical density.
Lutein, zeaxanthin, Vit.
C, and α-tocopherol.
High serum levels of lutein and zeax-
anthin may retard aging of the lens.
Delcourt et al.
(1999) [63]
2584 subjects, >60 years. To determine
plasma levels of antioxidant enzymes
related with cataract and age-related mac-
ular degeneration.
Enzymes: GPx and SOD.
High levels of plasma GPx were
associated with age-related macular
degeneration and cataract prevalence.
High levels of plasma SOD were asso-
ciated with high cataract prevalence.
Delcourt et al.
(2003) [64]
1947subjects,>60years.Todeterminethe
association between antioxidant enzymes
activity and incidence of cataract.
Enzymes: SOD and GPx.
High levels of plasma GPx and SOD
were associated with high cataract
incidence.
Gale et al.
(2001) [65]
372 subjects of 66 to 75 years. To deter-
mine plasma levels of some vitamins
and carotenoids related with cataract risk
incidence.
Vit. C, Vit. E, α and
β-carotene, lycopene,
lutein, zeaxanthin, and
β-cryptoxanthin.
High levels of α-carotene, β-carotene,
lycopene and lutein were associated
with low risk of cataract.
Jacques et al.
(2001) [66]
478 women of 53 to 73 years. To assess
therelationbetweenusualnutrientintake,
plasma vitamins concentration and sub-
sequently diagnosed age-related nuclear
lens opacities.
Vit. C, Vit. E, riboﬂavin,
β-carotene, lutein, and
zeaxanthin.
High Vit. C intake is associated with
low risk of cataract incidence. High
Vit. C and Vit. E plasma concentra-
tions are associated with low lenticu-
lar opacity.
Lyle et al.
(1999) [67]
400 subjects of 50 to 86 years, 7 years
followup. To assess the relation of serum
carotenoids and tocopherols levels to the
incidence of cataract.
Carotenoids,
α-tocopherol, and
γ-tocopherol.
H i g hs e r u ml e v e l so ft o c o p h e r o l sa r e
associated with low risk of cataract.
Vit. C: vitamin C; Vit. E: vitamin E; GPx: glutathione peroxidase; SOD: superoxide dismutase; CAT: catalase.
Table 2: Animal research comparing antioxidants and/or plasma levels of antioxidants molecules with degenerative changes in dogs.
Authors Objective Antioxidants Conclusion
Barros et al. (1999) [49]
To determine the erythrocytic
enzymatic antioxidants, plasma
V i t .Ca n dM D Ai nn o r m a l
and cataractous English Cocker
Spaniel dogs.
Enzymes: SOD, CAT,
GPx, and G6PD.
Vit. C.
Decrease levels of plasma Vit. C are
r e l a t e dw i t hc a t a r a c t .
Barros et al. (2003) [32]
To determined the antioxidant
status of the aqueous humor after
extracapsular lens extraction.
Total antioxidant status
and Vit C.
Lens surgical procedures reduced
total antioxidant status and Vit. C
levels.
Barros et al. (2004) [69]
To determined levels of enzy-
matic and nonenzymatic antiox-
idants in blood and aqueous
humor of cataractous and non-
cataractous poodles.
Enzymes: SOD, CAT,
GPx, and G6PD.
Vit. C.
Activity of SOD, G6PD, and CAT was
signiﬁcantly higher in noncataractous
poodles than in cataractous poodles.
There was no diﬀerence in mean
plasma Vit. C concentration between
cataractous and noncataractous dogs.
De Biaggi et al. (2006) [48]
To determined the antioxidant
status of the aqueous humor after
phacoemulsiﬁcation.
Total antioxidant status
and Vit. C.
Lens surgical procedures reduced
total antioxidant status and Vit. C
levels.
Vit. C: vitamin C; GPx: glutathione peroxidase; SOD: superoxide dismutase; CAT: catalase; MDA: malondialdehyde; G6PD: glucose-6-phosphate dehydroge-
nase.
To evaluate the total antioxidant capacity is accepted to
determine the capacity of the tissue or ﬂuid to inhibit a
speciﬁc free radical [32, 48, 68] or determine the GSH/GSSG
ratio and ascorbic acid/dehydroascorbate ratio [6].
4.2. Damage Assessment. To assess the damage, we can
use the identiﬁcation and quantiﬁcation of proteins, lipids,
and other substances from damaged cell. The biomarkers
frequently used are carbonyl and sulfhydryl levels [16]. In
the course of an oxidative process, carbonyl groups are
formed into the amino acid chain mainly in the lysine,
arginine, proline, and histidine residues. These carbonyl
can be detected by spectrophotometric methods, high-
pressure liquid chromatography (HPLC), or enzyme-linked6 Veterinary Medicine International
immunosorbent assay (ELISA) technique. To assess the
integrity of lipids, the measurement of membrane lipid
peroxidation is a key indicator [70]. The most common
method for assessing LPO, due to its simplicity and low cost,
is the measurement of MDA as thiobarbituric acid reactive
substance (TBARS) [6, 70].
5. Conclusions
Asmentioned,theeyeisexposedtooxidizingconditionsthat
lead to an alteration of ocular tissue, impaired vision, and,
in turn, the animal’s relationship with the surrounding envi-
ronment. The importance of assessing oxidative stress in the
globe lies in identifying the magnitude and extent of damage
that occurs in this condition. It is necessary to establish
treatment regimens to prevent and repair damage by ROS.
This last point is being addressed by some research groups
inducing or determining the incidence of ocular diseases and
comparing the intake of antioxidants and/or blood levels of
these(Table1).Itisestablishedthatitisimportanttohavean
optimal level of antioxidants to maintain ocular tissues safe,
but it is not clear if consumption of those antioxidant could
help to achieve this gold. Veterinary literature in this topic
seems to be limited (Table 2).
Models to study oxidative stress have yielded promising
results in relation with the use of antioxidants in diet. How-
ever, the results cannot be completely conﬁrmed because of
the inability to measure accurately the intake of antioxidants
in humans, and also it is unlikely to extrapolate results
from studies made in laboratory animals. There are other
drawbacks to recommend antioxidant intake due to the fact
that it is possible that an excessive consumption can lead to
other diseases such as formation of bladder stones by eating
high concentrations of vitamin C. Negligent administration
of supplements without having more knowledge of dosages
and good employment conditions may actually speed up
rather than suppress oxidative damage.
It would be desirable to know the normal antioxidant
status of the eye in each animal species and have better
or less invasive ways to evaluate it, such as measure blood
antioxidant proﬁle and determine how it relates to the
antioxidant proﬁle or damage of a speciﬁc ocular tissue. It is
also an important goal ﬁnd diﬀerent ways to strengthening
antioxidant defences and stop oxidative damage. There is
an open door to start new research in this area with many
questions to resolve.
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